References
Dietze M, Shin YS (2004) Biochemical diagnosis of Niemann-Pick disease A, B and C: the important role of sphingomyelinase. Bratisl Lek Listy 105:321
McGovern MM, Pohl-Worgall T, Deckelbaum RJ, Simpson W, Mendelson D, Desnick RJ, Schuchman EH, Wasserstein MP (2004) Lipid abnormalities in children with types A and B Niemann Pick disease. J Pediatr 145:77–81
Lee CY, Krimbou L, Vincent J, Bernard C, Larramee P, Genest J Jr, Marcil M (2003) Compound heterozygosity at the sphingomyelin phosphodiesterase-1 (SMPD1) gene is associated with low HDL cholesterol. Hum Genet 112:552–562
Muller P, Felin R, Lambrecht J, Agostini B, Wieland H, Rost W, Seidel D (1974) Hypertriglyceridaemia secondary to liver disease. Eur J Clin Invest 4:419–428
Patterson MC, Di Bisceglie AM, Higgins JJ, Abel RB, Schiffmann R, Parker CC, Argoff CE, Grewal RP, Yu K, Pentchev PG (1993) The effect of cholesterol-lowering agents on hepatic and plasma cholesterol in Niemann-Pick disease type C. Neurology 43:61–64
Simonaro CM, Desnick RJ, McGovern MM, Wasserstein MP, Schuchman EH (2002) The demographics and distribution of type B Niemann-Pick disease: novel mutations lead to new genotype/phenotype correlations. Am J Hum Genet 71:1413–1419
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Choi, JH., Shin, YL., Kim, GH. et al. Treatment of hyperlipidemia associated with Niemann-Pick disease type B by fenofibrate. Eur J Pediatr 165, 138–139 (2006). https://doi.org/10.1007/s00431-005-0009-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-005-0009-8